; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (172) Foramsulfuron formulations Heading 9902.09.87 is amended— (A) by amending the article description to read as follows: Mixtures of 2-[[[[(4,6-dimethoxy-2-pyrimidinyl)amino]carbonyl]amino]sulfonyl]-4-(formylamino)-N,N-dimethylbenzamide (Foramsulfuron) (CAS No. 173159–57–4) and application adjuvants (provided for in subheading 3808.93.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (173) Indaziflam and rimsulfuron formulations Heading 9902.09.90 is amended— (A) by amending the article description to read as follows: Product mixtures containing N-[(1R,2S)-2,6-dimethyl-2,3-dihydro-1H-inden-1-yl]-6-[(1R)-1-fluoroethyl] -1,3,5-triazine-2,4-diamine (Indaziflam) (CAS No. 950782–86–2) and N-[(4,6-dimethoxy-2-pyrimidinyl) carbamoyl] -3-(ethylsulfonyl)-2-pyridinesulfonamide (Rimsulfuron) (CAS No. 122931–48–0) (provided for in subheading 3808.93.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (174) Paclobutrazol formulations Heading 9902.09.92 is amended— (A) by amending the article description to read as follows: Mixtures of (2RS, 3RS)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pentan-3-ol (Paclobutrazol) (CAS No. 76738–62–0) and application adjuvants (provided for in subheading 3808.93.15) ; and (B) by striking 12/31/2020 and inserting 12/31/2025 . (175) Prosulfuron Heading 9902.09.93 is amended— (A) by amending the article description to read as follows: Mixtures of N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl]-2-(3,3,3-trifluoropropyl) benzenesulfonamide (Prosulfuron) (CAS No. 94125–34–5) and application adjuvants (provided for in subheading 3808.93.15)